Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

Between 2010 and 2022, cardiovascular mortality increased in rural areas and decreased in urban areas, according to a study ...

Investors interested in stocks from the Medical - Products sector have probably already heard of Haemonetics (HAE) and Boston Scientific (BSX). But which of these two companies is the best option for ...

Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).

Albert K. Chin, MD, has spent over 35 years working in the field of medical technologies, having earned a great deal of ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Donald J. Trump’s second presidency may significantly alter health care and public health in Minnesota, especially if Robert F. Kennedy Jr. gets the opportunity to bring his vaccine skepticism to ...

In a new study, researchers from Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center (BMC) have found teaching artistic observation to neurology residents contributed ...